Prosecution Insights
Prosecution Insights
7 pending office actions • 2 clients • 7 examiners • 7 art units • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (14%) |
| Double-patenting only | 4 (57%) |
| Double-patenting + other | 1 (14%) |
| No statute on record | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TAYLOR, LIA ELAN | 1 | 64.1% | +28.6% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| CHONG, YONG SOO | 1 | 43.6% | +41.4% |
| NEAGU, IRINA | 1 | 46.7% | +57.7% |
| MIDDLETON, DANAYA L | 1 | 44.8% | +54.9% |
| CRAIGO, WILLIAM A | 1 | 49.3% | +38.9% |
| BAEK, BONG-SOOK | 1 | 41.5% | +69.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17226058 | CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION | CRAIGO, WILLIAM A | 4d overdue |
| 18265525 | CYCLOBENZAPRINE TREATMENT FOR FIBROMYALGIA | CHONG, YONG SOO | 26d |
| 17623710 | ANTI-CD154 ANTIBODIES AND USES THEREOF | MIDDLETON, DANAYA L | 70d |
| 18271098 | METHODS OF INDUCING IMMUNE TOLERANCE WITH MODIFIED ANTI-CD154 ANTIBODIES | TAYLOR, LIA ELAN | — |
| 18212500 | CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF (SARS)-CoV-2 INFECTION (PASC) | BARSKY, JARED | — |
| 18037815 | CYCLOBENZAPRINE TREATMENT FOR ALCOHOL USE DISORDER | NEAGU, IRINA | — |
| 17269106 | METHODS OF TREATING ACUTE STRESS DISORDER AND POSTTRAUMATIC STRESS DISORDER | BAEK, BONG-SOOK | — |
| Client (Assignee) | Pending OAs |
|---|---|
| TONIX PHARMA LIMITED | 6 |
| Tonix Pharma Limited | 1 |
| Art Unit | Apps |
|---|---|
| 1641 | 1 |
| 1628 | 1 |
| 1623 | 1 |
| 1629 | 1 |
| 1674 | 1 |
| 1615 | 1 |
| 1611 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18271098 | METHODS OF INDUCING IMMUNE TOLERANCE WITH MODIFIED ANTI-CD154 ANTIBODIES | Tonix Pharma Limited | TAYLOR, LIA ELAN | 1641 | DP | Non-Final OA | — | Pending | Jul 06, 2023 |
| 18212500 | CYCLOBENZAPRINE TREATMENT FOR POST-ACUTE SEQUELAE OF (SARS)-CoV-2 INFECTION (PASC) | Tonix Pharma Limited | BARSKY, JARED | 1628 | DP | Final Rejection | — | Pending | Jun 21, 2023 |
| 18265525 | CYCLOBENZAPRINE TREATMENT FOR FIBROMYALGIA | Tonix Pharma Limited | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | 26d | Pending | Jun 06, 2023 |
| 18037815 | CYCLOBENZAPRINE TREATMENT FOR ALCOHOL USE DISORDER | Tonix Pharma Limited | NEAGU, IRINA | 1629 | DP | Final Rejection | — | Pending | May 19, 2023 |
| 17623710 | ANTI-CD154 ANTIBODIES AND USES THEREOF | Tonix Pharma Limited | MIDDLETON, DANAYA L | 1674 | DPOther | Non-Final OA | 70d | Pending | Dec 29, 2021 |
| 17226058 | CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION | Tonix Pharma Limited | CRAIGO, WILLIAM A | 1615 | Other | Final Rejection | 4d overdue | Pending | Apr 08, 2021 |
| 17269106 | METHODS OF TREATING ACUTE STRESS DISORDER AND POSTTRAUMATIC STRESS DISORDER | Tonix Pharma Limited | BAEK, BONG-SOOK | 1611 | DP | Final Rejection | — | Pending | Feb 17, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial